affiliation not provided to SSRN
HNSCC, Response prediction, Radiotherapy, ex vivo assay, homologous recombination deficiency (HRD), tumor infiltrating lymphocytes
HNSCC, Recurrence, HPV-positive, DNA sequencing, circulating tumor DNA
HNSCC, response prediction, radiotherapy, ex vivo assay, homologous recombination deficiency (HRD), tumor infiltrating lymphocytes